Age-related macular degeneration and the incidence of cardiovascular disease: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wu, Juan ^a   Uchino, Miki ^b   Sastry, Srinivas M ^c   Schaumberg, Debra A ^a,d,e,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SUBURBAN HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PREDICTION; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SYSTEMATIC REVIEW; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; MACULAR DEGENERATION; META ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84899826457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089600     Document Type: Article

References (43)

1. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572. (Pubitemid 38456293)
2. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379: 1728-1738.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
4. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121: 519-526. (Pubitemid 36427639)
5. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109: 1767-1779.
6. Klein BE, Klein R, Lee KE, Jensen SC (2001) Measures of obesity and agerelated eye diseases. Ophthalmic Epidemiol 8: 251-262. (Pubitemid 32681945)
7. Mitchell P, Wang JJ, Smith W, Leeder SR (2002) Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 120: 1357-1363. (Pubitemid 36105441)
8. Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE, et al. (2008) Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115: 1046-1052 e1042.
9. Curcio CA, Millican CL, Bailey T, Kruth HS (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42: 265-274. (Pubitemid 32059440)
10. Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, et al. (2007) High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol 125: 300-305. (Pubitemid 46425556)
11. Mitta VP, Christen WG, Glynn RJ, Semba RD, Ridker PM, et al. (2013) CReactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts. JAMA Ophthalmol: 1-7.
12. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, et al. (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63: 200-206. (Pubitemid 30428336)
13. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141: 137-147. (Pubitemid 38937836)
14. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232. (Pubitemid 40696361)
15. Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, et al. (2006) A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47: 1568-1575. (Pubitemid 44313826)
16. Tan JS, Mitchell P, Smith W, Wang JJ (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114: 1143-1150. (Pubitemid 46829381)
17. Klein R, Klein BE, Tomany SC, Cruickshanks KJ (2003) The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110: 1273-1280.
18. Snow KK, Seddon JM (1999) Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 6: 125-143. (Pubitemid 29391400)
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Metaanalysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
20. Klein R, Davis MD, Magli YL, Segal P, Klein BE, et al. (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98: 1128-1134.
21. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1-30.
22. Wieberdink RG, Ho L, Ikram MK, Koudstaal PJ, Hofman A, et al. (2011) Agerelated macular degeneration and the risk of stroke: the Rotterdam study. Stroke 42: 2138-2142.
23. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301-1309.
24. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. (Pubitemid 34746062)
25. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
26. Duan Y, Mo J, Klein R, Scott IU, Lin HM, et al. (2007) Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 114: 732-737. (Pubitemid 46483682)
27. Liao D, Mo J, Duan Y, Klein R, Scott IU, et al. (2008) Is age-related macular degeneration associated with stroke among elderly americans? Open Ophthalmol J 2: 37-42.
28. Nguyen-Khoa BA, Goehring EL Jr, Werther W, Gower EW, Do DV, et al. (2008) Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 126: 1280-1286.
29. Hu CC, Ho JD, Lin HC (2010) Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke 41: 613-617.
30. Golan S, Shalev V, Goldstein M, Treister G, Chodick G, et al. (2011) The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study. Graefes Arch Clin Exp Ophthalmol 249: 179-182.
31. Knudtson MD, Klein BE, Klein R (2006) Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol 124: 243-249. (Pubitemid 43247075)
32. Wong TY, Tikellis G, Sun C, Klein R, Couper DJ, et al. (2007) Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Ophthalmology 114: 86-91. (Pubitemid 46014277)
33. Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P (2008) Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92: 509-512. (Pubitemid 351497979)
34. Sun C, Klein R, Wong TY (2009) Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology 116: 1913-1919.
35. Ikram MK, Mitchell P, Klein R, Sharrett AR, Couper DJ, et al. (2012) Agerelated macular degeneration and long-term risk of stroke subtypes. Stroke 43: 1681-1683.
36. Fernandez AB, Wong TY, Klein R, Collins D, Burke G, et al. (2012) Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Ophthalmology 119: 765-770.
37. Clemons TE, Kurinij N, Sperduto RD (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122: 716-726. (Pubitemid 38607400)
38. Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P (2008) Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92: 509-512. (Pubitemid 351497979)
39. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, et al. (2010) Clinical risk factors for age-related macular degeneration: a systematic review and metaanalysis. BMC Ophthalmol 10: 31.
40. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29: 95-112.
41. Sofat R, Casas JP, Kumari M, Talmud PJ, Ireland H, et al. (2010) Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals. Atherosclerosis 213: 184-190.
42. Friedman E (2000) The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130: 658-663.
43. Shaw PX, Zhang L, Zhang M, Du H, Zhao L, et al. (2012) Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A 109: 13757-13762.